You must log in to view this page.

Sangamo Therapeutics Inc.

NASDAQ: SGMO
Share price (8/12/25): $0.52
Market cap (8/12/25): $156 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.4

from 8-K 27 pages Amendment No. 1 to the Tender Offer Agreement Between Txcell S.A. and Sangamo Therapeutics, Inc. Dated as of October 1st, 2018

12/34/56

EX-2.2

from 8-K 16 pages From: The Sellers. To: Sangamo Therapeutics, Inc. 501 Canal Blvd, Richmond Ca 94804 United States of America October 1st, 2018 Amendment Agreement to the Spa (The “Amendment Agreement”) Dear Sirs,

12/34/56

EX-2.2

from 8-K 29 pages Tender Offer Agreement Between Txcell S.A. and Sangamo Therapeutics, Inc. Dated as of July 20, 2018

12/34/56

EX-2.1

from 8-K 24 pages Share Purchase Agreement

12/34/56

EX-2.1

from 8-K 71 pages Agreement and Plan of Merger by and Among Sangamo Biosciences, Inc. Cg Acquisition Sub, Inc. and Ceregene, Inc. and Hamilton Bioventure Services, Inc., as Stockholders’ Representative Dated as of August 23, 2013

12/34/56

EX-2.1

from 8-K 46 pages Asset Purchase Agreement

12/34/56

EX-2.1

from 8-K ~50 pages Dated June 28, 2001 the Sellers Named in Schedule 1a and Sangamo Biosciences Inc. Agreement for the Sale and Purchase of All the Issued Share Capital of Gendaq Limited Brobeck Hale and Dorr Alder Castle 10 Noble Street London Ec2v 7qj Tel: +44 (0)20 7645 2400 Fax: +44 (0)20 7645 2424 Contents

12/34/56

Sangamo Therapeutics Inc. Watch

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

Sangamo Therapeutics Inc.